Fidelity provided a $4.8m second tranche after a first close featuring KNC, Ohar Pharmaceutical, Spera Pharma, Kisco and SRD Holdings.
Month: January 2021
Nibiru visualises series C1 funding
Real estate developer Dahua’s Huaqiang Capital unit has injected hundreds of millions of yuan into the AR/VR technology provider.
McKesson Ventures lifts Lee to senior director
The healthcare product provider has promoted Lizzie Lee to lead portfolio development and market research at its corporate venturing unit.
Jumbotail jumps to series B3 round
Nutresa contributed to a $14.2m round that increased the grocery trading platform developer’s overall funding to approximately $54m.
Angi Homeservices picks up Umbrella
Alphabet’s Sidewalk Labs has exited the domestic assistance provider in an acquisition by Angi Homeservices.
Showcase Gig finds Glory in new round
The currency processing equipment provider has backed a $9.6m round that pushed mobile payment technology developer Showcase Gig’s total funding to $48m.
Media into money
A lot of innovation comes from looking at an established company or industry through a new prism.
SoftBank fits into $360m Keep series F
The fitness class provider roughly doubled its valuation to $2bn in a round led by SoftBank Vision Fund that included Bertelsmann Asia Investments and Tencent.
WorkTrans undertakes $140m series D
Tencent participated in the HR management software provider’s series D round, which was disclosed together with $50.5m in series C funding.
MadeiraMadeira kits out $190m round
The furniture-focused e-commerce platform secured the funding in a round co-led by SoftBank as it looks to expand its physical footprint and launch own-brand products.
Digital Alpha connects to WeLink with $185m
The Cisco-affiliated asset managment firm is now the largest external investor in fixed-wireless broadband service WeLink.
Mynt rolls out details of $175m investment
Alibaba-affiliated Bow Wave Capital Management has invested $175m in the financial services provider, a joint venture by Globe Telecom, Ant Group and Ayala.
Visen Pharmaceuticals entices Ascendis to $150m round
The endocrine disease drug developer completed a series B round that included $125m from former parent company Ascendis.
F5 to enfold Volterra in $500m deal
Itochu Technology Ventures, M12 and Samsung Next are set to exit the cloud services technology developer in a purchase by F5 Networks.